Drug Master Files for: LOXAPINE HYDROCHLORIDE
✉ Email this page to a colleague
LOXAPINE HYDROCHLORIDE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
13135 | I | II | 8/14/1998 | INSTITUTE DRUG TECHNOLOGY AUSTRALIA LTD | LOXAPINE BASE |
23144 | A | II | 9/30/2009 | MEDICHEM SA | LOXAPINE BASE |
29977 | A | II | 11/6/2015 | CENTAUR PHARMACEUTICALS PRIVATE LTD | LOXAPINE SUCCINATE USP |
3447 | I | II | 2/2/1979 | AMERICAN CYANAMID CO | LOXITANE (LOXAPINE SUCCINATE POWDER), AMOXAPINE |
6767 | A | II | 12/29/1986 | MEDICHEM SA | LOXAPINE SUCCINATE |
7577 | I | II | 7/11/1988 | MIKAH PHARMA LLC | LOXAPINE SUCCINATE |
8812 | I | II | 11/5/1990 | PROFARMACO SRL | LOXAPINE SUCCINATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information